levodopa has been researched along with Age-Related Memory Disorders in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (12.90) | 18.7374 |
| 1990's | 5 (16.13) | 18.2507 |
| 2000's | 13 (41.94) | 29.6817 |
| 2010's | 9 (29.03) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dagher, A; Fellows, LK; Simioni, AC | 1 |
| Kim, HJ; Kim, KS; Lee, KE; Lee, MK; Park, HJ; Shin, KS; Zhao, TT | 2 |
| Bourgois, N; De Schlichting, E; Deffond, D; Durif, F; Ferrier, A; Jean, B; Marques, A; Mathais, S; Merlin, C; Valla, C; Vidal, T | 1 |
| Denibaud, AS; Drieu La Rochelle, C; Loiodice, S; Méot, B; Montagne, P; Rion, B; Viel, R; Wing Young, H | 1 |
| Brown, JA; Conyers, S; Dearborn, JT; Diggs-Andrews, KA; Gutmann, DH; Izumi, Y; Tokuda, K; Wozniak, DF; Yuede, CM; Zorumski, CF | 1 |
| Limón, ID; Palafox-Sánchez, V; Ramírez-García, G | 1 |
| Danysz, W; Dekundy, A; Gravius, A; Morè, L; Nagel, J; Pietraszek, M | 1 |
| Amalric, M; De Leonibus, E; Giordani, F; Lopez, S; Managò, F; Mele, A; Oliverio, A; Petrosino, F | 1 |
| Cho, JY; Cho, YJ; Hong, KS; Jeon, BS; Kim, HJ; Lee, DH; Park, SY; Seo, SY | 1 |
| Gabriel, D; Guggisberg, A; Morand, S; Nahum, L; Schnider, A | 1 |
| Calabresi, P; Costa, C; de Iure, A; Di Filippo, M; Di Luca, M; Gardoni, F; Ghiglieri, V; Latagliata, EC; Marti, M; Morari, M; Pascucci, T; Pendolino, V; Picconi, B; Puglisi-Allegra, S; Sgobio, C; Siliquini, S; Spillantini, MG; Tantucci, M; Tozzi, A | 1 |
| Angelucci, ME; Canteras, NS; Da Cunha, C; Takahashi, RN; Wonnacott, S | 1 |
| Ginestroni, A; Marini, P; Paganini, M; Ramat, S | 1 |
| Brusa, L; Caltagirone, C; Koch, G; Oliveri, M; Stanzione, P | 1 |
| Bottiglieri, T; Diaz-Arrastia, R; Greenberg, SM; Growdon, JH; Gurol, ME; Hyman, BT; Irizarry, MC; Locascio, JJ; Raju, S; Tennis, M | 1 |
| Berry-Kravis, E; Hagerman, PJ; Hagerman, RJ; Hall, DA; Leehey, MA; Rice, CD | 1 |
| Ambrée, O; de Souza Silva, MA; Dere, E; Herring, A; Keyvani, K; Lewejohann, L; Paulus, W; Richter, H; Sachser, N; Schäbitz, WR | 1 |
| Brusa, L; Caltagirone, C; Carlesimo, GA; Costa, A; Gatto, I; Peppe, A | 1 |
| Russ, MO; Seger, L | 1 |
| Cooper, JA; Sagar, HJ; Sullivan, EV | 1 |
| Cabaret, M; Caparros-Lefebvre, D; Godefroy, O; Petit, H; Rémy, P; Samson, Y; Steinling, M | 1 |
| Cyong, J; Itokazu, N; Ouchi, Y; Yamamoto, K | 1 |
| Baillet, C; Callizot, N; Guénet, JL; Poindron, P; Warter, JM | 1 |
| Canteras, NS; Da Cunha, C; Gevaerd, MS; Miyoshi, E; Silveira, R; Takahashi, RN | 1 |
| Kristensen, V; Olsen, M; Theilgaard, A | 1 |
| Arbit, J; Blonsky, ER; Boshes, B; Dolkart, M; Kovach, JW | 1 |
| Cooper, JA; Doherty, SM; Jordan, N; Sagar, HJ; Sullivan, EV; Tidswell, P | 1 |
| Benke, T; Berger, W; Poewe, W; Schelosky, L | 1 |
| Reynolds, CM; Riklan, M; Stellar, S | 1 |
| Huber, SJ; Paulson, GW; Shulman, HG; Shuttleworth, EC | 1 |
1 review(s) available for levodopa and Age-Related Memory Disorders
| Article | Year |
|---|---|
The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities.
Topics: Animals; Caffeine; Disease Models, Animal; Humans; Levodopa; Memory Disorders; Neurons; Parkinsonian Disorders; Rats; Receptors, Dopamine; Receptors, Purinergic P1; Substantia Nigra | 2002 |
4 trial(s) available for levodopa and Age-Related Memory Disorders
| Article | Year |
|---|---|
Dopaminergic modulation of rapid reality adaptation in thinking.
Topics: Adaptation, Psychological; Adult; Brain; Cognition Disorders; Dopamine; Dopamine Agents; Dopamine Antagonists; Double-Blind Method; Humans; Levodopa; Male; Memory; Memory Disorders; Mental Processes; Neural Inhibition; Neuropsychological Tests; Psychoses, Substance-Induced; Risperidone | 2010 |
Memory for time intervals is impaired in left hemi-Parkinson patients.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Female; Functional Laterality; Humans; Levodopa; Memory Disorders; Middle Aged; Parkinson Disease; Task Performance and Analysis; Time Factors | 2005 |
Levodopa treatment of presenile dementia.
Topics: Adult; Cognition Disorders; Dementia; Drug Evaluation; Female; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Wechsler Scales | 1977 |
Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients.
Topics: Adult; Aged; Bromocriptine; Cognition Disorders; Female; Follow-Up Studies; Frontal Lobe; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Motor Activity; Movement; Parasympatholytics; Parkinson Disease; Psychomotor Performance; Visual Perception | 1992 |
26 other study(ies) available for levodopa and Age-Related Memory Disorders
| Article | Year |
|---|---|
Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
Topics: Aged; Brain Mapping; Dopamine; Executive Function; Female; Humans; Levodopa; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Nerve Net; Neural Pathways; Parietal Lobe; Parkinson Disease | 2017 |
Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Chemistry; Disease Models, Animal; Gynostemma; Levodopa; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Plant Extracts; Spatial Memory | 2017 |
Subacute corticobasal syndrome following internal carotid endarterectomy.
Topics: Aged; Basal Ganglia Diseases; Cerebral Hemorrhage; Cerebrovascular Circulation; Diffusion Magnetic Resonance Imaging; Dopamine Agents; Endarterectomy, Carotid; Hemiplegia; Humans; Hypoxia, Brain; Levodopa; Magnetic Resonance Imaging; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography; Postoperative Complications; Tomography, X-Ray Computed | 2018 |
Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson's disease.
Topics: Amphetamine; Animals; Antiparkinson Agents; Anxiety; Benserazide; Disease Models, Animal; Dopamine; Forelimb; Gait Disorders, Neurologic; Interpersonal Relations; Levodopa; Locomotion; Male; Maze Learning; Memory Disorders; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 2019 |
Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice.
Topics: Animals; Behavior, Animal; Depression; Disease Models, Animal; Dopamine Agents; Electrophysiology; Female; Humans; Integrases; Levodopa; Male; Maze Learning; Memory Disorders; Mice; Mice, Knockout; Mice, Transgenic; Motivation; Neurofibromatosis 1; Neurofibromin 1 | 2013 |
Nitrosative and cognitive effects of chronic L-DOPA administration in rats with intra-nigral 6-OHDA lesion.
Topics: Animals; Antiparkinson Agents; Astrocytes; Carbidopa; Corpus Striatum; Gliosis; Levodopa; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Oxidopamine; Parkinsonian Disorders; Pars Compacta; Prefrontal Cortex; Rats, Wistar; Spatial Memory | 2015 |
Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.
Topics: Animals; Antiparkinson Agents; Avoidance Learning; Corpus Striatum; Dioxoles; Dopamine; Dose-Response Relationship, Drug; Levodopa; Lignans; Male; Memory; Memory Disorders; Mice, Inbred C57BL; Motor Activity; Nootropic Agents; Parkinsonian Disorders; RNA, Messenger; Substantia Nigra | 2016 |
Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in rats.
Topics: Animals; Antiparkinson Agents; Anxiety Disorders; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Glutamic Acid; Learning Disabilities; Levodopa; Male; Maze Learning; Memory Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Synaptic Transmission; Thiazoles | 2008 |
Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease.
Topics: Animals; Association Learning; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Levodopa; Male; Memory Disorders; Mice; Movement; Oxidopamine; Parkinson Disease; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Space Perception; Vision Disorders | 2009 |
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Indoles; Levodopa; Male; Memory Disorders; Middle Aged; Mood Disorders; Movement Disorders; Neurologic Examination; Nocturia; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Prevalence; Restless Legs Syndrome; Treatment Outcome | 2009 |
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease.
Topics: alpha-Synuclein; Analysis of Variance; Animals; Antiparkinson Agents; Benserazide; Biophysical Phenomena; Disease Models, Animal; Dopamine; Electric Stimulation; Excitatory Postsynaptic Potentials; Exploratory Behavior; Hippocampus; Humans; Levodopa; Long-Term Potentiation; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microdialysis; Mutation; Oxidopamine; Parkinson Disease; Patch-Clamp Techniques; Radionuclide Imaging; Rats; Subcellular Fractions; Sympatholytics; Synaptosomes; Tritium; Tyrosine 3-Monooxygenase | 2012 |
Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: reversal after L-dopa therapy.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cognition Disorders; Cross-Sectional Studies; Dopamine Agents; Drug Evaluation; Female; Humans; Language Tests; Levodopa; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Parkinson Disease; Verbal Learning | 2003 |
Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Brain; Causality; Cerebral Amyloid Angiopathy; Cognition Disorders; Creatinine; Female; Folic Acid; Homocysteine; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Predictive Value of Tests; Vitamin B 12 | 2005 |
Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome.
Topics: Adrenergic beta-Antagonists; Aged; Anxiety Disorders; Benzodiazepines; Carbidopa; Central Nervous System Agents; Cerebellar Ataxia; Cholinesterase Inhibitors; Dopamine Agonists; Female; Fragile X Syndrome; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neurologic Examination; Parkinsonian Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Tremor | 2006 |
Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Frontal Lobe; Hippocampus; Learning Disabilities; Levodopa; Male; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Nootropic Agents; Recognition, Psychology | 2009 |
Dopaminergic modulation of prospective memory in Parkinson's disease.
Topics: Adult; Aged; Cognition; Corpus Striatum; Dopamine Agonists; Female; Frontal Lobe; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Parkinson Disease; Severity of Illness Index; Treatment Outcome | 2008 |
The effect of task complexity on reaction times in memory scanning and visual discrimination in Parkinson's disease.
Topics: Adult; Aged; Female; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychometrics; Reaction Time; Task Performance and Analysis; Visual Perception | 1995 |
Short-term memory and temporal ordering in early Parkinson's disease: effects of disease chronicity and medication.
Topics: Adult; Aged; Brain; Bromocriptine; Dementia; Female; Frontal Lobe; Humans; Language Tests; Levodopa; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Parasympatholytics; Parkinson Disease; Psychiatric Status Rating Scales; Reaction Time; Task Performance and Analysis | 1993 |
PET study and neuropsychological assessment of a long-lasting post-encephalitic parkinsonism.
Topics: Aged; Antiparkinson Agents; Brain; Dihydroxyphenylalanine; Encephalitis, Arbovirus; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Levodopa; Memory Disorders; Neuropsychological Tests; Obsessive-Compulsive Disorder; Parkinson Disease; Phobic Disorders; Tomography, Emission-Computed | 1998 |
Establishment of L-3,4-Dihydroxyphenilalaninde-induced pharmacological dementia model mouse.
Topics: Administration, Oral; Animals; Antiparkinson Agents; Avoidance Learning; Cognition Disorders; Dementia; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Levodopa; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Stereoisomerism | 2001 |
The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Electromyography; Female; Genes, Recessive; Immunohistochemistry; Indoles; Levodopa; Male; Memory Disorders; Mice; Mice, Inbred C3H; Mice, Neurologic Mutants; Motor Activity; Neurons; Parkinson Disease, Secondary; Postural Balance; Selegiline; Tyrosine 3-Monooxygenase | 2001 |
L-Dopa restores striatal dopamine level but fails to reverse MPTP-induced memory deficits in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Avoidance Learning; Benserazide; Biogenic Monoamines; Brain Chemistry; Corpus Striatum; Dopamine; Dopamine Agents; Levodopa; Male; Memory Disorders; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 2001 |
The sixth year after L-dopa: quality of life and insights derived.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Parkinson Disease; Perceptual Disorders; Visual Perception | 1975 |
High-speed memory scanning in Parkinson's disease: adverse effects of levodopa.
Topics: Frontal Lobe; Humans; Levodopa; Memory Disorders; Memory, Short-Term; Mental Recall; Parkinson Disease; Psychological Tests; Receptors, Dopamine | 1991 |
Correlates of memory in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Amantadine; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Memory; Memory Disorders; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease | 1989 |
Dose-dependent memory impairment in Parkinson's disease.
Topics: Carbidopa; Dopamine; Drug Combinations; Humans; Levodopa; Memory Disorders; Parkinson Disease | 1989 |